Latest BioAlps news

News
Cancer Research: HES-SO Valais-Wallis and Debiopharm sign a partnership
The Life Technologies Institute of the Haute École d’Ingénierie has signed a new five-year collaboration agreement with Debiopharm Research &…
News
Cancer Research: ISREC Foundation and EPFL announce the creation of the Paternot Chair
The chair will be held by Professor Nicolas Thomä. The ISREC Foundation is contributing to the funding of the Chair…
News
HeroSupport wins a CHF 150,000 Venture Kick Grant
The HUG and UNIGE spin-off wants to improve cancer treatment universal access with tailored patient-positioning medical devices and standardized workflows….
News
Tune Insight raises CHF 3,1 Million
The round is led by 14Peaks Capital, with participation from investors including Inflection.xyz, Debiopharm Innovation Fund and Zurich Cantonal Bank….
News
Nagi Bioscience secures CHF 12.4 Million Investment
Nagi Bioscience, a Swiss life sciences company developing next-generation laboratory equipment to unlock the full potential of alternatives to animal…
News
Debiopharm Innovation Fund: a new seed fund dedicated to Digital Health
Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, announces the launch…
News
Atinary Technologies raises CHF 4.6 Million
The Biopôle-based start-up has developed a machine learning platform dedicated to materials discovery. The seed-round was round led by AgFunder…
News
Future Health Grant – 9 new projects selected
This great Swiss Health Valley🇨🇭 initiative was started by CSS and EPFL Innovation Park to promote Medicine 3.0. The 9…
News
Future Health Lausanne, an opportunity for the Swiss Health Valley
Future Health Lausanne is taking place on 3 October 2023 at the Swisstech Convention Center in Lausanne. The event is…
News
Adiposs SA announced the completion of the phase I clinical trial of its ImageBAT™
Adiposs SA, a Swiss biotech company developing medical imaging products and technologies, announced the completion of the phase I clinical…
News
A consortium led by Addex Therapeutics secures a €4 million Eurostars grant
The Geneva-based pharmaceutical company will use the grant to support its programme for mild neurocognitive disorders (mNCD). The…
News
Multiwave raises CHF 3.8 Million
Geneva-based deeptech startup Multiwave Technologies SA, led by Tryfon and Panos Antonakakis, is attracting new capital that will be dedicated…